The Latest Breaking News from FDA

The FDA asked advisers to take another look at phenylephrine, which became the main drug in over-the-counter decongestants when medicines with an older ingredient were moved behind pharmacy counters.

On Sept. 12, 2023, the Centers for Disease Control and Prevention recommended the newly formulated COVID-19 vaccines for all Americans ages 6 months and up, hours after its expert advisory committee voted 13 to 1 in favor of recommending the vaccines.

Chicago public health officials have said the CDC approval was all they needed to “begin the rollout” of the vaccine, which will be free for all city residents. “We already have the vaccine in Chicago,” Dr. Geraldine Luna, medical director for the Chicago Department of Public Health, said Monday.

The shots will protect against currently circulating variants of the SARS-CoV-2 virus

Advisers to the Food and Drug Administration voted unanimously on Tuesday against the effectiveness of the key drug phenylephrine found in popular versions of Sudafed, Dayquil and other medications stocked on store shelves.

As new variants of COVID are making the rounds, the Food and Drug Administration and Centers for Disease Control and Prevention have approved a new round of COVID-19 vaccines.

Advisory panel spent two days reviewing studies of phenylephrine, an active ingredient in Benadryl, Mucinex, Sudafed PE and Tylenol

Americans may soon be able to get an updated COVID-19 vaccine

An advisory panel told the Food and Drug Administration that the highly sought-after medicines may no longer be suitable for sale.

A panel of doctors and scientists advising the Centers for Disease Control and Prevention voted to recommend that people 6 months of age and older get new COVID boosters this fall.

US regulator says ingredient in popular High Street medications ‘not effective’ at standard doses